Shares of Auna S.A. (NYSE:AUNA – Get Free Report) have been assigned an average rating of “Hold” from the five brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, one has issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $6.9667.
AUNA has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Auna in a research report on Friday, March 27th. Zacks Research lowered shares of Auna from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 31st. JPMorgan Chase & Co. decreased their target price on shares of Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 26th. Finally, Wall Street Zen downgraded shares of Auna from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 16th.
View Our Latest Stock Analysis on AUNA
Auna Price Performance
Auna (NYSE:AUNA – Get Free Report) last released its earnings results on Friday, May 15th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.14). The business had revenue of $336.84 million during the quarter, compared to the consensus estimate of $320.54 million. Auna had a net margin of 1.53% and a return on equity of 16.25%. On average, sell-side analysts forecast that Auna will post 0.81 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, President Leon Jesus Zamora acquired 6,420 shares of Auna stock in a transaction that occurred on Friday, May 29th. The shares were acquired at an average price of $4.15 per share, for a total transaction of $26,643.00. Following the transaction, the president directly owned 69,130 shares of the company’s stock, valued at approximately $286,889.50. The trade was a 10.24% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John Wilton sold 17,574 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $4.17, for a total value of $73,283.58. Following the completion of the transaction, the director owned 49,974 shares of the company’s stock, valued at $208,391.58. This represents a 26.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have purchased a total of 83,454 shares of company stock worth $357,063 in the last 90 days.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in AUNA. World Investment Advisors acquired a new position in Auna in the 4th quarter valued at approximately $52,000. Clear Harbor Asset Management LLC bought a new stake in shares of Auna in the fourth quarter worth $63,000. Sanctuary Advisors LLC bought a new stake in shares of Auna in the first quarter worth $71,000. Virtu Financial LLC acquired a new stake in Auna in the third quarter valued at $75,000. Finally, Sage Investment Counsel LLC increased its holdings in Auna by 60.0% in the fourth quarter. Sage Investment Counsel LLC now owns 16,000 shares of the company’s stock valued at $79,000 after purchasing an additional 6,000 shares during the period.
About Auna
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
See Also
- Five stocks we like better than Auna
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
